Price History
Feb 9, 2026 — May 18, 2026Investment Snapshot
- Piotroski F-Score 1/9 — signs of financial weakness
- Negative net margin (-1,392.6%) — currently unprofitable
- Revenue growing at 17% annually
YD Bio Limited - Ordinary Shares (YDES) is a Healthcare company operating in Services-Medical Laboratories, listed on the NASDAQ , with a market capitalisation of $366 million . Key value metrics: Piotroski F-Score 1 out of 9 .
Value Score
Key Metrics
YD Bio Limited - Ordinary Shares — Fundamental Analysis Summary
StockPik's composite Value Score for YDES is 42/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
YDES reports a moderate gross margin of 28.1% (sector average: 40.1%) and a negative operating margin of -883.3%.
YDES shows revenue growing at 17% year-over-year, with earnings declining at 489%.